Press release
Breast Biopsy Devices Market to Reach USD 3.26 Billion by 2030 Driven by Diagnostic Innovation
Breast Biopsy Devices Market
The growing preference for outpatient biopsies, driven by cost-effectiveness, supportive reimbursement structures, and personalized treatment strategies, further accelerates market expansion. North America leads the market with a 43.8% share, supported by advanced healthcare infrastructure, active screening programs, and high disease awareness. Biopsy needles dominate product segment sales, reflecting their essential role in modern image-guided procedures.
Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/breast-biopsy-devices-market?utm_source=OpenPR&utm_campaign=Onkar
Key Highlights from the Report
➤ The global market is projected to reach USD 3.26 billion by 2030 at a 6.5% CAGR.
➤ Biopsy needles remain the dominant product segment due to wide clinical use.
➤ Hospitals & surgical centers represent the largest end-user segment.
➤ North America leads with 43.8% market share in 2024.
➤ Technological advancements in imaging and AI integration boost precision.
➤ Rising awareness and national screening programs enhance market penetration.
Market Segmentation
By product type, biopsy needles accounted for the largest revenues in 2024 owing to their widespread use in both core-needle and vacuum-assisted procedures. Their compatibility with multiple imaging modalities, such as MRI and ultrasound, coupled with cost-effectiveness, strengthens their dominance. Additionally, the rising trend toward outpatient and minimally invasive biopsies underscores continued demand for these instruments.
By application, the therapy selection segment exhibits the fastest growth rate, supported by personalized medicine trends. Oncologists increasingly rely on biopsy samples to identify tumor-specific biomarkers, guide targeted treatment decisions, and monitor therapeutic response, driving robust global demand in this category.
By end user, hospitals and surgical centers dominate the market. Their advanced diagnostic infrastructure, specialized oncology departments, and skilled medical professionals ensure optimal patient outcomes. The integration of automated radiology workflows and digital imaging systems further strengthens operational efficiency within these institutions.
Get Customization in the Report as Per Your Business Requirements: https://www.datamintelligence.com/customize/breast-biopsy-devices-market?utm_source=OpenPR&utm_campaign=Onkar
Regional Insights
North America captured the largest market share in 2024 due to its mature healthcare systems, advanced imaging infrastructure, and strong presence of leading device manufacturers such as Hologic and Danaher. Supportive programs like the Breast and Cervical Cancer Mortality Prevention Act and breast density notification laws have improved screening participation and access to care.
Europe follows closely, characterized by well-established reimbursement systems, ongoing national screening initiatives, and rapid adoption of minimally invasive biopsy devices. China emerges as the fastest-growing market between 2025 and 2030, attributed to increased government health expenditure, improved hospital access, and awareness campaigns promoting early diagnosis.
Market Dynamics
Market Drivers:
The increasing preference for minimally invasive biopsy methods, such as core-needle and vacuum-assisted techniques, is reducing patient recovery time and cost while improving diagnostic efficiency. The ability to perform biopsies in outpatient setups further accelerates adoption across healthcare systems.
Market Restraints:
High costs associated with advanced imaging-guided biopsy equipment remain a significant barrier, particularly in low-resource and public healthcare settings. The price sensitivity of devices-ranging from USD 15,000 to USD 100,000 for certain imaging systems-restricts widespread adoption.
Market Opportunities:
Technological advancements in ultrasound and MRI-guided diagnostics, supplemented by artificial intelligence integration, are reshaping accuracy standards in breast cancer detection. With enhanced image resolution and automation, clinicians can conduct earlier and more reliable biopsies, opening new revenue streams for device innovators.
Purchase This Exclusive Report at Just USD 6128 Only: https://www.datamintelligence.com/buy-now-page?report=breast-biopsy-devices-market?utm_source=OpenPR&utm_campaign=Onkar
Reasons to Buy the Report
✔ In-depth market analysis supported by verified DataM Intelligence insights.
✔ Comprehensive segmentation by product, application, and end user.
✔ Regional analysis highlighting key growth regions and emerging markets.
✔ Coverage of technological advancements and their commercial implications.
✔ Strategic intelligence for investors, manufacturers, and healthcare providers.
Frequently Asked Questions (FAQs)
◆ How Big is the Global Breast Biopsy Devices Market in 2025?
◆ What is the Projected Growth Rate of the Breast Biopsy Devices Market through 2030?
◆ Who are the Key Players Driving Innovation in Breast Biopsy Devices?
◆ Which Region Holds the Largest Market Share in 2024?
◆ What Technological Advances Are Shaping the Future of Breast Biopsy Devices?
Company Insights
Hologic Inc.
Becton, Dickinson and Company
Devicor Medical Products Inc.
Argon Medical Devices
Merit Medical Systems, Inc.
Varian Medical Systems, Inc.
Recent Developments:
In 2023, Menarini Silicon Biosystems partnered with Alivio Health to enhance access to its CELLSEARCH CTC tests for continuous patient monitoring.
In 2023, Merit Medical Systems acquired Angio Dynamics' biopsy and dialysis catheter portfolio for USD 100 million, strengthening its oncology device portfolio.
In 2022, Guardant Health collaborated with Merck KGaA to advance biomarker-driven therapy development for key cancer targets.
Conclusion
The global breast biopsy devices market is set for consistent growth, driven by technological advancements, policy support, and rising awareness of early diagnosis. As healthcare transitions toward precision medicine and minimally invasive care, device manufacturers and clinical providers are investing in next-generation imaging and AI-assisted biopsy platforms. With increasing global focus on early cancer detection, the market's expansion through 2030 represents a pivotal stride toward improving survival outcomes and diagnostic efficiency across the healthcare continuum.
Contact Us
Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
Visit Our Website: https://www.datamintelligence.com
About Us
DataM Intelligence 4Market Research is a comprehensive market intelligence platform offering syndicated and customized reports along with expert consulting across multiple industries, including chemicals, healthcare, agriculture, food & beverages, and more. With extensive experience and a strategy-focused approach, DataM provides businesses and individuals with reliable market insights, statistical forecasts, and personalized research solutions to help them make informed decisions and successfully bring innovations to market.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Breast Biopsy Devices Market to Reach USD 3.26 Billion by 2030 Driven by Diagnostic Innovation here
News-ID: 4235871 • Views: …
More Releases from DataM Intelligence
Europe Sports Nutrition Market to Reach USD 9.20 Billion by 2030 Driven by Perfo …
The Europe sports nutrition market is experiencing strong momentum, standing at USD 6.13 billion in 2025 and projected to attain USD 9.20 billion by 2030, according to DataM Intelligence. This growth, at an impressive 8.47% CAGR, underscores the region's rising integration of sports nutrition into lifestyle and wellness choices. Expanding adoption by millennials, Gen Z, and active seniors is reshaping consumption habits from athletic use to daily health maintenance. The…
Food Supplement Market Poised to Surpass US$ 345.13 Billion by 2031 Driven by Ag …
According to DataM Intelligence, the Global Food Supplement Market reached US$ 203.10 billion in 2024 and is forecasted to reach US$ 345.13 billion by 2031, expanding at a CAGR of 8.4% during 2025-2031. The driving force behind this growth is the global rise in aging populations coupled with increasing awareness of preventive healthcare and healthy living. As individuals age, challenges such as weakened immunity, cognitive decline, joint pain, and bone-related…
Biofuels Market Size to Reach US$ 252.19 Billion by 2032 Driven by Clean Energy …
The global biofuels market, valued at US$ 153.88 billion in 2024, is expected to reach US$ 252.19 billion by 2032, registering a compound annual growth rate (CAGR) of 6.4% between 2025 and 2032. Rising environmental concerns, greenhouse gas reduction targets, and global commitments toward clean energy are driving the shift toward biofuels as a sustainable replacement for fossil fuels.
According to the World Bioenergy Association's 2024 Global Bioenergy Statistics Report, biofuels…
Industrial Gases Market to Hit High Growth by 2031 Driven by Hydrogen & Semicond …
The global industrial gases market is poised for steady growth over the forecast period, with a projected compound annual growth rate (CAGR) of 6.11% from 2024 to 2031. Depending on the source and forecast period, estimates range from 5% to 11%, underscoring a healthy upward trend. Key drivers include the expansion of the chemical, healthcare, and electronics sectors, ongoing industrialization in emerging economies, and the accelerating demand for hydrogen-particularly green…
More Releases for Biopsy
Liquid Biopsy Market - Unlocking Insights in Liquid: Transforming the Biopsy Lan …
Newark, New Castle, USA: The "Liquid Biopsy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Liquid Biopsy Market: https://www.growthplusreports.com/report/liquid-biopsy-market/8430
This latest report researches the industry structure, sales, revenue,…
Biopsy Devices Market Overview by Breast Biopsy, Lung Biopsy, Prostate Biopsy to …
Download Free PDF Sample Papers Now at Biopsy Devices Market https://www.reportsnreports.com/contacts/requestsample.aspx?name=1159148 .
Biopsy devices market report analyzes various types of biopsy devices in market and their adoption patterns. It aims at estimating market size and future growth potential of biopsy devices market for different segments such as product, guidance technique, application, end user, and region. Global biopsy devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East…
Biopsy Device Market to Increase to US$ 2,621 Mn by 2026 | Guidance System (Ster …
Key players focussing on strategic M&A for amplified market shares
Patients are increasingly preferring minimally invasive surgical procedures in order to avoid conventional surgical complications and side-effects, promoting sales of biopsy devices, leading to the growth of the biopsy devices globally. In addition to enabling the accurate diagnosis, a biopsy device assures minimal patient discomfort and trauma. This is identified to be a major factor impacting the popularity of biopsy, and…
Breast Biopsy Market Report 2018: Segmentation by Product (Vacuum Assisted Biops …
Global Breast Biopsy market research report provides company profile for Hologic Inc., Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.), C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume,…
Biopsy Devices Market Report 2018: Segmentation by Product (Core Needle Biopsy, …
Global Biopsy Devices market research report provides company profile for C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth…
Bone Biopsy Market 2018 | Needle Biopsy | Open Biopsy | Bone Cancer | Bone Infec …
The Global Bone Biopsy Market is growing continuously and expected to grow at a CAGR of 5.7% from 2017 to 2023. Bone biopsy is performed to diagnose various bone disorders such as bone cancer, bone infection, osteoporosis and chronic kidney disease. Nowadays, biopsy procedure has received great importance in oncology as one of the promising methods in cancer diagnostics. The demand for needle biopsy is found to be increasing from…
